Last reviewed · How we verify
Pfs25 VLP- FhCMB — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Pfs25 VLP- FhCMB (Pfs25 VLP- FhCMB) — Fraunhofer, Center for Molecular Biotechnology.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Pfs25 VLP- FhCMB TARGET | Pfs25 VLP- FhCMB | Fraunhofer, Center for Molecular Biotechnology | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Pfs25 VLP- FhCMB CI watch — RSS
- Pfs25 VLP- FhCMB CI watch — Atom
- Pfs25 VLP- FhCMB CI watch — JSON
- Pfs25 VLP- FhCMB alone — RSS
Cite this brief
Drug Landscape (2026). Pfs25 VLP- FhCMB — Competitive Intelligence Brief. https://druglandscape.com/ci/pfs25-vlp-fhcmb. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab